Viatris Maintained at Buy by UBS
UBS has maintained its Buy rating on Viatris.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
UBS has maintained its Buy rating on Viatris.
Analysts' ratings for high-yielding health care stocks: Viatris, Medtronic, and GSK.